89 results
Page 3 of 5
424B3
nzsjs9sb hu9
22 Nov 13
Prospectus supplement
12:00am
8-K
EX-99
u2x7erd
28 Oct 13
Cellceutix Enters into New $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
12:00am
8-K
EX-99.1
6on2a1us
9 Sep 13
Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
12:00am
8-K
EX-99.1
f9kb9sv53hzv8
4 Mar 13
Cellceutix Signs with Leading Cancer Center For Licensing New Drug
12:00am
8-K
EX-99.1
mxhqhmsuw72h08l2
26 Dec 12
Cellceutix Comments on New York Times Article Heralding p53 Drugs as the New Age in Cancer Research
12:00am
8-K
EX-99.1
j1n7f6wxaz5
10 Dec 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
64m3bzihevf2zgycyrh
22 Jun 12
Cellceutix Approved By FDA to Proceed with Clinical Trials on Novel Cancer Drug
12:00am